PCLOF (PharmaCielo) Short-Term Debt: $13.52 Mil (As of Dec. 2025)


What is PharmaCielo Short-Term Debt?

PharmaCielo PCLOF -29.85% Short-Term Debt is $13.52 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

PharmaCielo's Short-Term Debt for the quarter that ended in Dec. 2025 was $13.52 Mil.

PharmaCielo's quarterly Short-Term Debt declined from Jun. 2025 ($15.22 Mil) to Sep. 2025 ($12.88 Mil) but then increased from Sep. 2025 ($12.88 Mil) to Dec. 2025 ($13.52 Mil).

PharmaCielo's annual Short-Term Debt increased from Dec. 2021 ($0.06 Mil) to Dec. 2022 ($0.41 Mil) and increased from Dec. 2022 ($0.41 Mil) to Dec. 2023 ($11.71 Mil).

PharmaCielo Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

PharmaCielo Short-Term Debt Related Terms

PharmaCielo Short-Term Debt Historical Data

* Premium members only.

The historical data trend for PharmaCielo's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCielo Short-Term Debt Chart

PharmaCielo Annual Data
Trend Aug17 Aug18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial 0.00 0.07 0.06 0.41 11.71

PharmaCielo Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.16 11.12 15.22 12.88 13.52
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $13.52 Mil mean?
PharmaCielo (PCLOF) has a Short-Term Debt of $13.52 Mil as of Dec. 2025.
Is PharmaCielo's Short-Term Debt too high?
PharmaCielo's current Short-Term Debt is $13.52 Mil.
How does PharmaCielo's Short-Term Debt compare to ZTS and UTHR?
PharmaCielo's Short-Term Debt of $13.52 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. PharmaCielo's current Short-Term Debt is $13.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCielo stock overvalued right now?
Based on GuruFocus' analysis, PharmaCielo (PCLOF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.11, compared to a current price of $0.04 — trading 60.9% below its estimated fair value. The current Short-Term Debt is $13.52 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For PharmaCielo (PCLOF), the current Short-Term Debt is $13.52 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCielo Business Description

Other Exchanges PCLO:Canada
Address 82 Richmond Street East, Suite 805, Toronto, ON, CAN, M5C 1P1
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico and generates the majority of its revenue in the form of the Sale of Cannabis derivative products in America followed by Australia, Africa and Europe.